Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06151912
Other study ID # E-16214662-050.01.04-254590-62
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 1, 2023
Est. completion date July 30, 2024

Study information

Verified date November 2023
Source Sakarya University
Contact Adem Yuksel, M.D
Phone +905053455259
Email ademyuksel@sakarya.edu.tr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Obesity is a significant public health problem. The only long-term effective treatment method is surgery. The most common surgical procedure is laparoscopic sleeve gastrectomy (LSG). However, after LSG, complications such as gastroesophageal reflux disease (GERD), insufficient weight loss, stenosis in the remnant stomach, and bleeding or leakage in the staple line (SL) may be encountered. The most severe complications are leakage and bleeding in sleeve gastrectomy, which can lead to many morbidities and mortality. Strengthening the staple line is an important option to prevent these complications. Methods such as fibrin adhesives, bioabsorbable patches and stitching of the stapler line are used to strengthen the stapler line. Nausea and vomiting, which occur in the postoperative period in 40% of patients who have undergone abdominal surgery and constitute a serious problem, are detected at an even higher rate in patients who have undergone bariatric surgery. Additionally, strengthening the staple line with various methods may increase the incidence of nausea and vomiting after LSG. Although there are studies in the literature investigating whether strengthening the staple line with buttress material or suture in laparoscopic sleeve gastrectomy affects the incidence of postoperative nausea and vomiting, there is no study investigating the effect of strengthening the staple line with fibrin glue on the incidence of postoperative nausea and vomiting. This prospective study aims to reveal whether there is a difference between strengthening the staple line with fibrin glue or suture in LSG regarding the incidence of postoperative nausea and vomiting and its effects on quality of life.


Description:

Bleeding and leaks may occur in the stapler line after sleeve gastrectomy. To prevent these complications, the staple line can be strengthened. More than 60% of bariatric surgeons perform interventions to strengthen the staple line in sleeve gastrectomy. Two surgeons will perform the operations. One of the surgeons will suture the staple line. The other will apply fibrin glue to the stapler line. Study: It will be held between June 2023 and June 2024. The same anaesthesia protocol will be applied to all patients during the surgery; All patients will be administered fentanyl 2 mg kg-1, propofol 2.5 mg kg-1 and rocuronium 0.6 mg kg-1 based on lean body weight (LBW) for anaesthesia induction after 3 minutes of preoxygenation. After orotracheal intubation is performed under the guidance of a video laryngoscope and endotracheal intubation is confirmed, 1.0 Minimum alveolar concentration (MAC) value sevoflurane and 1:1 oxygen-air will be used for anaesthesia maintenance. Additional doses of rocuronium were administered if surgically necessary. Ventilation will be applied with a tidal volume of 6-8 ml kg-1 according to the ideal body weight for lung protective ventilation, along with a respiratory frequency at a level to ensure normocapnia (EtCO2 35-45 mmHg). For intraoperative analgesia, remifentanil infusion will be administered at a 0.1-0.3 mcg kg-1 min-1 dose according to ideal body weight. All patients will be given 0.15 mg kg-1 (maximum 16 mg) of ondansetron as an antiemetic. In recovery, sugammadex will be used at a 4-8 mg kg-1 dose to reverse the neuromuscular blockade. For acute postoperative analgesia, 100 mg tramadol, 1000 mg paracetamol and 50 mg dexketoprofen will be administered. No routine postoperative antiemetic medication will be used. Quality of life index and nausea and vomiting score survey forms will be filled out for patients in the preoperative period, at the 6th, 24th hour and 1st postoperative hour. According to these filled-out forms, the patient's nausea and vomiting scores and quality of life scores will be calculated. Patients included in both groups will be compared to these scores. This study aims to determine whether there is a difference in strengthening the staple line with fibrin glue or sutures in sleeve gastrectomy regarding the incidence of postoperative nausea and vomiting and its effects on quality of life.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date July 30, 2024
Est. primary completion date June 30, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Patients with a body mass index of 40 kg/m2 and above Exclusion Criteria: - Patients with hiatal hernia, gastritis or ulcer detected during endoscopy - Smoker - Patients who have previously had another bariatric procedure - Patients who have previously undergone gastrointestinal system surgery - Patients with any contraindications for bariatric surgery

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Postoperative Nausea and Vomiting scala
The Nausea and Vomiting Intensity Scale will be used. Patients will be evaluated with this scale at 1, 6, 24 hours and one month. According to this scale, A total score of =50 at any time during the study period will be defined as clinically significant nausea and vomiting.
Quality of life
The EuroQol Group (EQ-5D-5L) questionnaire will assess the quality of life in five domains (mobility, personal care, usual activities, pain and anxiety). A higher score indicates more excellent quality of life impairment. The survey will be administered to patients immediately before surgery and 24 hours and four weeks after surgery to establish baseline values.

Locations

Country Name City State
Turkey Sakarya University Sakarya Adapazari

Sponsors (1)

Lead Sponsor Collaborator
Sakarya University

Country where clinical trial is conducted

Turkey, 

References & Publications (2)

Naeem Z, Nie L, Drakos P, Yang J, Gan TJ, Pryor AD, Spaniolas K. The Relationship Between Postoperative Nausea and Vomiting and Early Self-Rated Quality of Life Following Laparoscopic Sleeve Gastrectomy. J Gastrointest Surg. 2021 Aug;25(8):2107-2109. doi: 10.1007/s11605-021-04923-4. Epub 2021 Feb 2. No abstract available. — View Citation

Ruiz-Tovar J, Zubiaga L, Munoz JL, Llavero C. Incidence of postoperative nausea and vomiting after laparoscopic sleeve gastrectomy with staple line reinforcement with oversewing and staple line inversion vs buttressing material: A randomized clinical trial. Int J Surg. 2018 Nov;59:75-79. doi: 10.1016/j.ijsu.2018.09.010. Epub 2018 Oct 3. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Age Years 1 day First application
Other Body Mass Index (Index) kg/m2 1 day First application
Other Body mass Index kg/m2 Postoperative 1 month
Primary Postoperative nausea and vomiting intensity scale (6. hours) Question 1. Have you vomited or had dry-retching?
No 0 point
Once or twice 2 point
Three or more times 50 points
Question 2. Have you experienced a feeling of nausea? If yes, has your feeling interfered with being able to get out of bed, walking, eating or drinking?
No 0 point
Sometimes 1 point
Often or most of the time 2 point
All of the time 25 point
Question 3. Has your nausea been mostly:
Varying ("comes and goes") 1point
Constant 2 point
Question 4. What was the duration of your feeling of nausea (in hours)?
…, … (hours). If the answer to Q1=c), score=50 Otherwise, select the highest score of Q1 or Q2, the multiply x Q3 x Q4 Postoperative nausea and vomiting intensity score:
Postoperative 6 hours
Primary Postoperative nausea and vomiting intensity scale (24. hours) Question 1. Have you vomited or had dry-retching?
No 0 point
Once or twice 2 point
Three or more times 50 points
Question 2. Have you experienced a feeling of nausea? If yes, has your feeling interfered with being able to get out of bed, walking, eating or drinking?
No 0 point
Sometimes 1 point
Often or most of the time 2 point
All of the time 25 point
Question 3. Has your nausea been mostly:
Varying ("comes and goes") 1point
Constant 2 point
Question 4. What was the duration of your feeling of nausea (in hours)?
…, … (hours). If answer to Q1=c), score=50 Otherwise, select the highest score of Q1 or Q2, the multiply x Q3 x Q4
Postoperative nausea and vomiting intensity score:
Postoperative 24 hours
Primary Postoperative nausea and vomits intensity scale (72. hours) Question 1. Have you vomited or had dry-retching?
No 0 point
Once or twice 2 point
Three or more times 50 points
Question 2. Have you experienced a feeling of nausea? If yes, has your feeling interfered with being able to get out of bed, walking, eating or drinking?
No 0 point
Sometimes 1 point
Often or most of the time 2 point
All of the time 25 point
Question 3. Has your nausea been mostly:
Varying ("comes and goes") 1point
Constant 2 point
Question 4. What was the duration of your feeling of nausea (in hours)?
…, … (hours). If answer to Q1=c), score=50 Otherwise, select the highest score of Q1 or Q2, the multiply x Q3 x Q4 Postoperative nausea and vomiting intensity score:
Postoperative 72 hours
Primary Quality of life (index) The EuroQol Group (EQ-5D-5L) questionnaire will be used to evaluate quality of life.
According to the survey, patients will be evaluated in five areas (mobility, self-care, usual activities, pain, and anxiety).
Baseline (Index)
Primary Quality of life (24. hours) The EuroQol Group (EQ-5D-5L) questionnaire will be used to evaluate quality of life.
According to the survey, patients will be evaluated in five areas (mobility, self-care, usual activities, pain, and anxiety).
Postoperative 24 hours
Primary Quality of life (72. hours) The EuroQol Group (EQ-5D-5L) questionnaire will be used to evaluate quality of life.
According to the survey, patients will be evaluated in five areas (mobility, self-care, usual activities, pain, and anxiety).
Postoperative 72 hours
Primary Quality of life (1. month) The EuroQol Group (EQ-5D-5L) questionnaire will be used to evaluate quality of life.
According to the survey, patients will be evaluated in five areas (mobility, self-care, usual activities, pain, and anxiety).
Postoperative 1 month
Primary Postoperative nausea and vomiting intensity scale (1. month) Question 1. Have you vomited or had dry-retching?
No 0 point
Once or twice 2 point
Three or more times 50 points
Question 2. Have you experienced a feeling of nausea? If yes, has your feeling interfered with being able to get out of bed, walking, eating or drinking?
No 0 point
Sometimes 1 point
Often or most of the time 2 point
All of the time 25 point
Question 3. Has your nausea been mostly:
Varying ("comes and goes") 1point
Constant 2 point
Question 4. What was the duration of your feeling of nausea (in hours)?
…, … (hours). If answer to Q1=c), score=50 Otherwise, select the highest score of Q1 or Q2, the multiply x Q3 x Q4
Postoperative nausea and vomiting intensity score:
Postoperative 1 month
See also
  Status Clinical Trial Phase
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04622618 - Optimal Dosing of Preoperative Gabapentin for Prevention of Postoperative Nausea and Vomiting Early Phase 1
Completed NCT03599427 - Added Value of Systemic Lidocaine on Postoperative Pain, Opiate Use and Nausea After Knee Arthroscopy Phase 4
Recruiting NCT05975385 - Acupuncture for Prevention of Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy N/A
Recruiting NCT04589429 - Adding Nalbuphine for Control of Intrathecal Morphine Pruritus Phase 2
Recruiting NCT04654429 - Does Higher OT Temperature and IV Ondansetron Reduce Incidence of PSS in Parturients? Phase 4
Completed NCT05947981 - Pre-operative 5% Dextrose Infusion & PONV N/A
Recruiting NCT06137976 - Surgeon Perception of Gastric Decompression at Time of Gynecologic Laparoscopy N/A
Recruiting NCT06114277 - The Relationship Between Intraoperative ETCO2 Levels and Postoperative Pain and Nausea-Vomiting
Recruiting NCT04618146 - Enhanced Recovery After Cesarean Section With Low Dose Intrathecal Morphine. N/A
Active, not recruiting NCT03645239 - Post-operative Emesis and Pain Outcomes After Cesarean Delivery
Completed NCT04610398 - Perioperative Dexamethasone Reduces Postoperative Pain and Nausea After Hip Arthroscopy Phase 3
Completed NCT03130218 - Aromatherapy in Management of Postoperative Nausea in Post-Bariatric Surgery Patients N/A
Not yet recruiting NCT06439121 - The 4-7-8 Breathing Technique on Pain and Nausea-Vomiting N/A
Completed NCT03577496 - Does Aromatherapy Decrease Postoperative Nausea and Vomiting? N/A
Completed NCT04762381 - Dexamethasone and Robotic-assisted Hysterectomy N/A
Not yet recruiting NCT04442568 - Impact of ERAS in LSG N/A
Completed NCT03727607 - TIVA Versus Desfluran Anaesthesia in Patients Undergoing Bariatric Surgery Phase 2
Recruiting NCT06110416 - Decreasing Post-Operative Nausea and Vomiting in the Bariatric Surgical Patient N/A
Not yet recruiting NCT06137924 - Intraoperative Autonomic Neural Blockade Phase 3